Compare BioNTech SE - ADR (BNTX) vs Rockwell Automation (ROK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BioNTech SE - ADR vs Rockwell Automation — how do they compare? BioNTech SE - ADR trades at $92.8 (market cap $23.31B), while Rockwell Automation trades at $448.94 (market cap $49.64B). The key difference: Rockwell Automation is far larger — about 2.1× BioNTech SE - ADR's market cap, and Rockwell Automation pays a 1.23% dividend while BioNTech SE - ADR pays none. Which is the better fit depends on your goals.
| BNTX | ROK | |
|---|---|---|
Market Cap | $23.31B | $49.64B |
Sector | Health | Industrials |
52-Week High | $119.34 | $495.08 |
52-Week Low | $83.89 | $333.75 |
Enterprise Value | $6.60B | $52.77B |
Dividend Yield | — | 1.23% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BioNTech SE - ADR
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →About Rockwell Automation
Rockwell Automation is a pure-play automation competitor that is the successor entity to Rockwell International, which spun off its former Rockwell Collins avionics segment in 2001. As of fiscal 2021, the firm operates through three segments--intelligent devices, software and control, and lifecycle services. Intelligent devices contains its drives, sensors, and industrial components, software and control contains its information and network and security software, while lifecycle services contains its consulting and maintenance services as well as its Sensia JV with Schlumberger.
Read more on ROK →
